沃特世公司公布2025年第三季度强劲业绩——TipRanks
Waters Corporation Reports Strong Q3 2025 Results - TipRanks
生物技术与制药领域的最新动态
Waters Corporation Reports Strong Q3 2025 Results - TipRanks
Waters Corporation (NYSE:WAT) Beats Q3 Sales Expectations - TradingView
Waters Corporation (WAT) Projects Q4 Revenue Increase and EPS Gr - GuruFocus
Earnings call transcript: Waters Corporation beats Q3 2025 earnings expectations - Investing.com
Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena
Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold - BioSpace
Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win - Fierce Pharma
Roche signs $2B pact to pilot Manifold Bio's shuttles to the brain - Fierce Biotech
Roche taps an AI specialist to craft new brain drugs - BioPharma Dive
How Investors Are Reacting To Thermo Fisher Scientific (TMO) Product Launches and Strong Quarterly Results - simplywall.st
Thermo Fisher Scientific Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily
Illumina (ILMN) Soars 23.4% on Earnings Beat - Yahoo Finance
Waters Corporation (WAT) Q3 Earnings: What To Expect - Markets Financial Content
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario - MedCity News
Investors in Thermo Fisher Scientific (NYSE:TMO) have seen returns of 15% over the past three years - Yahoo Finance
Manifold Bio Announces Strategic Collaboration with Roche to Develop Multiple Next-Generation Brain Shuttles for Neurological Diseases - Business Wire
Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq
Illumina (ILMN) Returns to Profitability, Undervalued Versus Peers but Growth Lags Market - Yahoo Finance
Agilent Technologies (A): Evaluating Valuation as New CFO Adam Elinoff Joins to Drive Strategic Transformation - Yahoo Finance
Bones and Blood: Uncovering History Through DNA